What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Sergio Giralt focuses on Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Gastroenterology.
Internal medicine and Oncology are frequently intertwined in his study.
He has included themes like Survival rate, Regimen and Immunology in his Transplantation study.
His Surgery study frequently draws connections between related disciplines such as Transplantation Conditioning.
His Hematopoietic stem cell transplantation research focuses on Cancer and how it connects with Cohort.
The various areas that Sergio Giralt examines in his Gastroenterology study include Tacrolimus, Cumulative incidence, Complication, Immunopathology and Hodgkin's lymphoma.
His most cited work include:
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (1499 citations)
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION (1441 citations)
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. (1155 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Transplantation, Surgery, Oncology and Hematopoietic stem cell transplantation.
In most of his Internal medicine studies, his work intersects topics such as Gastroenterology.
In his work, Myeloid is strongly intertwined with Leukemia, which is a subfield of Transplantation.
Surgery is closely attributed to Bone marrow in his research.
The study incorporates disciplines such as CD34, Myeloid leukemia, Disease and Toxicity in addition to Oncology.
The Hematopoietic stem cell transplantation study combines topics in areas such as Cancer, Survival rate, Hematology, Myelodysplastic syndromes and Transplantation Conditioning.
He most often published in these fields:
- Internal medicine (82.99%)
- Transplantation (62.51%)
- Surgery (38.00%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (82.99%)
- Transplantation (62.51%)
- Oncology (37.93%)
In recent papers he was focusing on the following fields of study:
Sergio Giralt spends much of his time researching Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Multiple myeloma.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, CD34 and Ex vivo.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Incidence and Acute leukemia.
His studies in Transplantation integrate themes in fields like Hematopoietic cell, Stem cell and Immunology, Lymphoma.
His work carried out in the field of Oncology brings together such families of science as Older patients, Cancer, Myeloid leukemia and Disease.
The Hematopoietic stem cell transplantation study combines topics in areas such as Salvage therapy and Retrospective cohort study.
Between 2017 and 2021, his most popular works were:
- Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (131 citations)
- Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant (118 citations)
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Multiple myeloma.
Sergio Giralt has researched Internal medicine in several fields, including Gastroenterology, Ex vivo and CD34.
His studies deal with areas such as Hematopoietic cell, Incidence, Hazard ratio, Confidence interval and Stem cell as well as Transplantation.
His Oncology study integrates concerns from other disciplines, such as Adverse effect, Myeloid leukemia and T cell, Immune system.
Sergio Giralt combines subjects such as Randomized controlled trial, Fludarabine, Graft-versus-host disease and Cohort with his study of Hematopoietic stem cell transplantation.
His Toxicity study combines topics from a wide range of disciplines, such as Surgery and Cytokine release syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
